AMINOPHYLLINE- aminophylline dihydrate injection, solution

País: Estados Unidos

Língua: inglês

Origem: NLM (National Library of Medicine)

Ingredientes ativos:

AMINOPHYLLINE DIHYDRATE (UNII: C229N9DX94) (THEOPHYLLINE ANHYDROUS - UNII:0I55128JYK)

Disponível em:

Cardinal Health

DCI (Denominação Comum Internacional):

AMINOPHYLLINE DIHYDRATE

Composição:

AMINOPHYLLINE DIHYDRATE 25 mg in 1 mL

Via de administração:

INTRAVENOUS

Tipo de prescrição:

PRESCRIPTION DRUG

Indicações terapêuticas:

Intravenous theophylline is indicated as an adjunct to inhaled beta-2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. Aminophylline is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product including ethylenediamine.

Resumo do produto:

Aminophylline Injection, USP 25 mg/mL is supplied in single-dose containers as follows: NDC No. Container Volume Total Content 55154-2366-8 Available overbagged with 1 vial per bag Partial-fill Fliptop Vial 10 mL 250 mg 55154-6987-8 Available overbagged with 1 vial per bag Partial-fill Fliptop Vial 20 mL 500 mg Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] PROTECT FROM LIGHT. Store in carton until time of use. SINGLE-DOSE CONTAINER. Discard unused portion. Revised: November, 2009 Printed in USA EN-2301 Hospira, Inc., Lake Forest, IL 60045 USA Repackaged By: Cardinal Health Zanesville, OH 43701  IA60040911

Status de autorização:

Abbreviated New Drug Application

Características técnicas

AMINOPHYLLINE- AMINOPHYLLINE DIHYDRATE INJECTION, SOLUTION
CARDINAL HEALTH
----------
AMINOPHYLLINE
INJECTION, USP
25 MG/ML AMINOPHYLLINE, DIHYDRATE
(EQUIVALENT TO 19.7 MG/ML OF ANHYDROUS THEOPHYLLINE)
AMPUL
FLIPTOP VIAL
Rx only
DESCRIPTION
Aminophylline Injection, USP is a sterile, nonpyrogenic solution of
aminophylline in water for injection.
Aminophylline (dihydrate) is approximately 79% of anhydrous
theophylline by weight. Aminophylline
Injection is administered by slow intravenous injection or diluted and
administered by intravenous
infusion.
The solution contains no bacteriostat or antimicrobial agent and is
intended for use only as a single-dose
injection. When smaller doses are required the unused portion should
be discarded.
Aminophylline is a 2:1 complex of theophylline and ethylenediamine.
Theophylline is structurally
classified as a methylxanthine. Aminophylline occurs as a white or
slightly yellowish granule or
powder, with a slight ammoniacal odor. Aminophylline has the chemical
name 1H-Purine-2, 6-dione,
3,7-dihydro-1,3-dimethyl-, compound with 1,2-ethanediamine (2:1). The
structural formula of
aminophylline (dihydrate) is as follows:
The molecular formula of aminophylline dihydrate is C
H N O • 2(H O) with a molecular weight
of 456.46.
Aminophylline Injection, USP contains aminophylline (calculated as the
dihydrate) 25 mg/mL (equivalent
to 19.7 mg/mL anhydrous theophylline) prepared with the aid of
ethylenediamine. The solution may
contain an excess of ethylenediamine for pH adjustment. pH is 8.8 (8.6
to 9.0). The osmolar
concentration is 0.17 mOsmol/mL (calc.).
CLINICAL PHARMACOLOGY
MECHANISM OF ACTION:
Theophylline has two distinct actions in the airways of patients with
reversible obstruction; smooth
muscle relaxation (i.e., bronchodilation) and suppression of the
response of the airways to stimuli (i.e.,
nonbronchodilator prophylactic effects). While the mechanisms of
action of theophylline are not known
16
24
10
4
2
nonbronchodilator prophylactic effects). While the mechanisms of
action of